This report also highlighted a role of SGLT2i in the modulation of NLRP3 and myeloid differentiation primary response 88 (MyD88)-related pathways, known to be involved in the cytokine release that characterizes HF [111]. The gene discussed is NLRP3; the disease is hydrops fetalis.